UBS Group AG
NYSE:UBSBanks - Diversified
+$1.10 today
- Market cap
- $139.77B
- Beta
- 0.84
- P/E (TTM)
- 20.2
- EPS (TTM)
- $2.52
- Dividend yield
- 2.12%
Volume 1.72M
Average 2.52M
UBS Common Stock Repurchased
Cash spent buying back the company's own shares.
UBS Group AGNYSE: UBS
Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026
Common stock repurchased turns positive
Q1 FY2026 common stock repurchased was $0, compared with -$1.3B a year earlier. Trailing-twelve-month common stock repurchased was -$3.45B. Over 3 fiscal years it compounded at -11.9% a year.
Context
- Common stock repurchased amounted to 5.6% of revenue in FY2025, up 1.6 pp from a year earlier.
- Common stock repurchased grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly common stock repurchased holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$862.82M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Repurchased history
USD · from the cash flow
- Latest · FY2025
- (4.11B) USD
- Year-over-year change
- -40.6%
| Period | Period end | Common Stock Repurchased | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.11B) | -40.6% |
| FY2024 | 2024-12-31 | (2.92B) | -5.1% |
| FY2023 | 2023-12-31 | (2.78B) | +53.7% |
| FY2022 | 2022-12-31 | (6.01B) | -79.8% |
| FY2021 | 2021-12-31 | (3.34B) | — |
Common Stock Repurchased vs competitors
How UBS compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +10.5% is the 7th highest of 9, against a peer median of +38.4%.
- Common stock repurchased amounts to 4.6% of revenue for UBS, versus a peer median of 9.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥530.38B JPY | — | +3.6% | 3.8% | |
| LTM Jun 2026 | $24.86B USD | +47.1% | +68.1% | 12.7% | |
| LTM Jul 2026 | CA$24.79B CAD | +29.6% | +13.4% | 22.0% | |
| LTM Sep 2026 | $23.38B USD | -27.5% | +48.3% | 7.7% | |
| LTM Jun 2026 | $21.3B USD | +71.1% | +77.7% | 12.2% | |
| LTM Jul 2026 | CA$20.62B CAD | +83.2% | +6.2% | 14.4% | |
| LTM Jun 2026 | $14B USD | +18.0% | +52.3% | 11.9% | |
| LTM Mar 2026 | €4.72B EUR | +0.0% | +25.8% | 6.6% | |
| LTM Mar 2026 | $3.45B USD | +10.5% | -11.9% | 4.6% | |
| LTM Sep 2026 | $2.63B USD | +151.1% | -18.7% | 2.0% | |
| LTM Jun 2026 | $0 USD | — | +74.7% | 0.0% | |
| Peer median (excluding UBS) | — | +38.4% | +37.1% | 9.8% | |
Competitors are the stored peer set for UBS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.49B | 7.66B | 27.87B | 5.15B | 6.18B |
| Depreciation & Amortization | 2.12B | 2.06B | 3.23B | 3.8B | 3.53B |
| Deferred Income Tax | 434M | 494M | (694M) | (495M) | (302.98M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (187.93M) | 18.23B | 90.1B | (20.8B) | 18.8B |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (187.93M) | 18.23B | 90.1B | (20.8B) | 18.8B |
| Other Non-Cash Items | 21.57B | (13.8B) | (34.43B) | 15.63B | (10.88B) |
| Operating Cash Flow | 31.43B | 14.65B | 86.07B | 3.28B | 17.33B |
| Capital Expenditures | (1.84B) | (1.64B) | (1.69B) | (2.01B) | (1.87B) |
| Acquisitions (Net) | 592M | 1.73B | 194.26M | 192M | 504.44M |
| Purchases of Investments | (6.22B) | (16.78B) | (14.24B) | (5.97B) | (30.37B) |
| Sales of Investments | 5.05B | 4.08B | 10.47B | 8.38B | 13.48B |
| Other Investing Activities | 295M | 161M | 108.5B | 106M | 165.77M |
| Investing Cash Flow | (2.12B) | (12.45B) | 103.23B | 709M | (18.09B) |
| Debt Repayment | 15.27B | (804M) | (53.08B) | (79.53B) | (17.01B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (3.34B) | (6.01B) | (2.78B) | (2.92B) | (4.11B) |
| Dividends Paid | (1.3B) | (1.67B) | (1.68B) | (2.26B) | (2.27B) |
| Other Financing Activities | (283M) | (616M) | (721M) | 546M | (1.09B) |
| Financing Cash Flow | 10.35B | (9.09B) | (58.26B) | (84.17B) | (24.48B) |
| Effect of Forex Changes | (5.31B) | (5.66B) | 13.96B | (15.94B) | 15.15B |
| Net Change in Cash | 34.34B | (12.55B) | 144.99B | (96.12B) | (10.08B) |
| Free Cash Flow | 29.58B | 13B | 84.38B | 1.27B | 15.46B |
UBS Group AG
NYSE:UBS
Intrinsic Alpha fair value
Locked
Current Price
$45.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.